Skip to content

A randomized controlled trial for improving oxidative stress and antioxidative potential in human

A randomized controlled trial for improving oxidative stress and antioxidative potential in human - A trial for improving oxidative stress and antioxidative potential

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012608
Enrollment
20
Registered
2013-12-17
Start date
2013-05-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Duration: 8 weeks Test material: FFC Pairogen 180 ml Tree times/day (540 ml/day) Duration: 8 weeks Test material: bottled water 500 ml One bottle per day (500 ml/day)

Sponsors

ORTHOMEDICO, Inc.
Lead Sponsor
Seishin-kai Medical Association Inc, Takara Medical Clinic.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a) Healthy adults, who feel fatigue daily b) Persons who are between 40 and 60 years old

Exclusion criteria

Exclusion criteria: a) Persons who have previous medical history of heart failure or myocardial infarction b) Patients being treated for at least one of following diseases; atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, and other chronic disease c) Persons who take medicines, herbal medicines, or dietary supplements d) Persons who are allergic to medicines, or foods related to the test material of this trial e) Pregnant women, lactating women, or women who want to get pregnant during the trial period f) Persons who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial g) Persons who are judged not suitable to participate in this trial by physician.

Design outcomes

Primary

MeasureTime frame
Oxidative stress and antioxidant potential potential anti oxidant (PAO) serum total antioxidant status (STAS) diacron-reactive oxygen metabolites (d-ROMs) bioantioxidant power (BAP) 8-hydroxy-2'-deoxyguanosine (8-OHdG) propanoyl lysine (PRL) hexanoyl lysine (HEL)

Secondary

MeasureTime frame
microarray analys8s of miRNA (performed to the part of participants) Questionnaires (Likert scale) Blood test Urianalysis Physical examinations

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO, Inc. R&D department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026